Barriers to Papanicolaou Screening among HIV-Infected Women: a cross sectional survey Arya Payan M.S., B.S. Touro University, Nevada University of Nevada.

Slides:



Advertisements
Similar presentations
4th Year Student Electives overseas HIV and Post- Exposure Prophylaxis Dr Eric Monteiro Clinical Director Department of Genitourinary Medicine.
Advertisements

Ending AIDS by 2030 World AIDS Day Commemoration Addis Ababa, Ethiopia, 25 November 2014.
00003-E-1 – December 2004 Global summary of the HIV and AIDS epidemic, December 2004 The ranges around the estimates in this table define the boundaries.
00002-E-1 – 1 December 2003 Global summary of the HIV/AIDS epidemic, December 2003 The ranges around the estimates in this table define the boundaries.
UNAIDS World AIDS Day Report | 2011 Core Epidemiology Slides.
2,100,000 Number of pregnant women with HIV/AIDS 200,000Number of pregnant women receiving PMTCT 630,000Number of MTCT new infections 2,000,000Number of.
Look for clues that will tell you about the movie’s plot as you watch this trailer.
HIV Therapy for the Developing World: A Global Health Challenge Harold W. Jaffe, MD Department of Public Health University of Oxford Oxford, UK.
Global Response to HIV/AIDS Nigerian Nurses Association of USA June 30, 2006 Carolyn M Hall, MSN/MPH, ACRN Global HIV/AIDS Program U.S. Department of Health.
HIV and AIDS from UNAIDS / WHO UNAIDS Report on the Global AIDS Epidemic
1 July 2008 e Global summary of the AIDS epidemic, December 2007 Total33 million [30 – 36 million] Adults30.8 million [28.2 – 34.0 million] Women15.5 million.
Whatever You Thought, Think Again.. A Very Delicate Virus Human Immunodeficiency Virus - HIV is full of contradictions – – Very fragile; fresh air destroys.
An Overview of TB in SAARC Countries and Role of SAARC TB Centre in TB Control Dr Paras K Pokharel, Associate Professor Dept. of Community Medicine, BPKIHS.
The mysterious emergence of HIV/AIDS Malthus’s ghost: is this a XXth century ‘positive’ check? Where does it come from? Runs counter to the idea that health.
AIDS in Sub Saharan Africa AIDS – a virus with no known cure first identified in the Belgian Congo in It’s now a global epidemic, and poverty and.
00003-E-1 – December 2005 Global summary of the HIV and AIDS epidemic, December 2005 The ranges around the estimates in this table define the boundaries.
Global HIV prevalence in adults, 1985 UNAIDS/WHO, 2006.
HIV and AIDS from UNAIDS / WHO UNAIDS Report on the Global AIDS Epidemic
THE IMPACT OF AIDS ON OUR CONTINENT An overview. Global estimates for adults and children, end 2002.
00002-E-1 – 1 December 2003 Adults and children estimated to be living with HIV/AIDS as of end 2003 Total: 34 – 46 million Western Europe – 680.
Eastern European Alliance for Reproductive Choice REPRODUCTIVE CHOICE FOR HIV- INFECTED WOMEN Prof. POSOKHOVA S.P. UKRAINE УКРАЇНАУКРАЇНА.
July 2015 Core Epidemiology Slides.
Central Asia Regional Health Security Workshop George C. Marshall European Center for Security Studies April 2012, Garmisch-Partenkirchen, Germany.
00002-E-1 – 1 December 2001 Global summary of the HIV/AIDS epidemic, December 2001 Number of people living with HIV/AIDS Total40 million Adults37.2 million.
1 Total 33.2 million [30.6 – 36.1 million] Adults 30.8 million [28.2 – 33.6 million] Women 15.4 million [13.9 – 16.6 million] Children under 15 years 2.5.
00002-E-1 – 1 December 2002 Global summary of the HIV/AIDS epidemic, December 2002 Number of people living with HIV/AIDS Total42 million Adults38.6 million.
Global HIV Epidemiology Carey Farquhar, MD, MPH Grace John-Stewart MD, PhD Departments of Medicine, Epidemiology and Global Health.
Universal Opt-Out Screening for HIV in Health Care Settings, Cost Effectiveness in Action Douglas K. Owens, MD, MS VA Palo Alto Health Care System and.
Using implementation science to improve child household contact screening for tuberculosis in Eldoret, Kenya: Overview and lessons learned Daria Szkwarko,
1 July 2008 e Global summary of the AIDS epidemic, December 2007 Total33 million [30 – 36 million] Adults30.8 million [28.2 – 34.0 million] Women15.5 million.
00002-E-1 – 1 December 2001 THE HIV/AIDS PANDEMIC Focus on Africa By Dr. David Elkins HIV/AIDS Prevention and Care Project Nairobi, Kenya September 2002.
HIV/AIDS. دسترسی به آموزش ،پیشگیری،مراقبت ودرمان ایدز حق هر انسان است بامشارکت در اطلاع رسانی گسترش خدمات پیشگیری ودرمان ،پرهیز از انگ وتبعیض همه ی افراد.
1 Module 1: [Basic] Unit 1: [HIV Epidemics and Key Populations] Lesson 2: [Levels of HIV Epidemic in the World] “Community-Based HIV Surveillance” Online.
1 06/06 e Global HIV epidemic, 1990 ‒ 2005*HIV epidemic in sub-Saharan Africa, 1985 ‒ 2005* Number of people living with HIV % HIV prevalence, adult (15-49)
Global Impact of HIV/AIDS Deborah Lewinsohn, M.D. Infectious Diseases, Pediatrics Vaccine and Gene Therapy Institute Oregon Health & Science University.
Core Epidemiology Slides
Global summary of the HIV and AIDS epidemic, December 2003
وضعیت HIV/AIDS در جهان و ايران
Regional HIV and AIDS statistics and features, 2006
Contents - HIV global slides
Global summary of the AIDS epidemic, December 2007
Overview of Global HIV Epidemic
Global summary of the HIV/AIDS epidemic, December 2003
The Cold Hard Facts… World Wide HIV/AIDS
Global summary of the AIDS epidemic, 2008
Global summary of the HIV/AIDS epidemic, December 2003
Estimated number of new HIV infections in young people
Global summary of the AIDS epidemic, 2008
Global epidemiology of injecting drug use
COLPOSCOPY Improving Patient Adherence and Understanding
Regional HIV and AIDS statistics and features, 2003 and 2005
Global summary of the HIV and AIDS epidemic, December 2004
ايدز.
Contents - HIV global slides
کلیات آموزش ایدز به زبان ساده
Estimated adult and child deaths from AIDS  2009
Global summary of the AIDS epidemic, December 2007
Contents - HIV global slides
Western & Central Europe
Global summary of the HIV/AIDS epidemic, December 2003
Global summary of the HIV and AIDS epidemic, 2005
Regional HIV and AIDS statistics 2008 and 2001
Global Summary of the HIV and AIDS Epidemic December 2004
Contents - HIV global slides
Children (<15 years) estimated to be living with HIV as of end 2005
Regional HIV and AIDS statistics and features for women, 2004 and 2006
Regional HIV and AIDS statistics and features, end of 2004
Global summary of the HIV and AIDS epidemic, 2005
Core epidemiology slides
July 2018 Core epidemiology slides.
Presentation transcript:

Barriers to Papanicolaou Screening among HIV-Infected Women: a cross sectional survey Arya Payan M.S., B.S. Touro University, Nevada University of Nevada School of Medicine HealthySunrise Foundation Saman S. Movahedi, Aaron T. Hunt, Dina V. Patel, Patricia Thomas, Alireza Farabi, Echezona E. Ezeanolue

Adults and children estimated to be living with HIV Middle East & North Africa [ – ] Sub-Saharan Africa 24.7 million [23.5 million – 26.1 million] Eastern Europe & Central Asia 1.1 million [ – 1.3 million] Asia and the Pacific 4.8 million [4.1 million – 5.5 million] North America and Western and Central Europe 2.3 million [2.0 million – 3.0 million] Latin America 1.6 million [1.4 million – 2.1 million] Caribbean [ – ]

Background on HIV/AIDS 35 million people live with HIV worldwide 46% women 1.15 million individuals in the United States 26% are women

1.5 million individuals died worldwide from AIDS in million individuals newly infected with HIV in 2013 Background on HIV/AIDS

Malignancy in HIV Increased risk of developing other disease Malignancies Cervical Cancer Papanicolaou (Pap.) smear is the currently recommended method of screening

HIV/AIDS in our Population Tri-county Area (Clark, Mojave and Nye) 8,484 people living with HIV/AIDS 1,371 (~16%) are women We work with women that receive care for their HIV/AIDS at the UMC Wellness Center

Study Objective and Design We sought to understand barriers to cervical cancer screening among HIV-infected women Our cohort was 318 HIV/AIDS positive women in our university-affiliated outpatient clinic

Methods Investigators contacted patients via telephone to complete an investigator administered 30-item questionnaire, 13 barriers questioned. 13 questions regarding potential barriers; some items asked: Date of last Pap. smear Perceived barriers to getting a Pap. smear Preferred method of contact for making a Pap. smear appointment and/or getting a reminder

Phone Call Methodology Attempt # 1 (10am to 4pm) Reached Survey Completed Survey Not Completed Not Reached Attempt #2 (evening or weekend) ReachedNot Reached Attempt #3 (evening or weekend) ReachedNot Reached

Results 141 patients were reached and 77 completed the survey (completion rate=55%) 46% did not receive Pap. smears in the past year

Results Perceived barriers to receiving Pap. smears were found Cost – 23% Lack of insurance – 14% Transportation – 12% Comfort level with physician – 6%

Results Among those that did NOT receive a Pap. smear within the last year, 45% reported that being contacted via text messaging would best aid them to come in more regularly

Discussion No single perceived barrier is likely affecting cervical cancer screening rates among HIV/AIDS positive women Rather a combination of factors This unique population deals with multiple medical and non-medical appointments related to their health Utilizing preferred communication methods for both scheduling and reminders is likely to increase screening rates among HIV/AIDS patients

How is texting being used internationally? Collectively known as “mHealth” Appointment reminding and making Emergencies and disasters Medication adherence Health education

“mHealth” in the Healthcare Setting Cincinnati Children’s Medical Center currently uses it throughout pregnancies; very positive outcomes Rural India Sub Saharan Africa mobile phone penetration in 2012 was 58%, expected to exceed 70% by 2015* Initial data is promising, but more research needed * Deloitte, 2012

Conclusion Automated text messaging is the preferred mode of contact for HIV-infected women in Southern Nevada Clinics should be flexible and strive to find innovative ways to match the needs of their patients

Acknowledgements Funding provided by: National Institutes of Health (NIH) HRSA - Ryan White CARE act Special Thanks to: Saman S. Movahedi, M.S. Aaron T. Hunt, M.P.H Dina V. Patel, A.P.N. Dr. Echezona E. Ezeanolue, M.D.

Thank You!